Gil Addo, MBA
Gil Addo is the Co-founder and former CEO of RubiconMD, now a subsidiary of CVS Health. Most recently, he served as Senior Vice President of Specialty Care Solutions at CVS Health. Founded in 2013, RubiconMD revolutionized healthcare by serving primary care clinicians across 37 states. The company was recognized by The Huffington Post as one of the “Five Companies Defining the Future of Healthcare” and, in 2020, was ranked #12 by AllianceBernstein on its list of the top 25 private companies disrupting the healthcare industry.
RubiconMD raised roughly $40 million in capital from top-tier investors and was acquired by Oak Street Health in 2021 for $190 million. Oak Street Health was subsequently acquired by CVS Health in 2023.
Before founding RubiconMD, Gil was a Consultant at Putnam Associates, a leading pharmaceutical strategy firm, where he developed payer and market access strategies for Fortune 500 clients. He also held strategy and business development roles at Xerox, Cubist (acquired by Merck), and two early-stage healthcare ventures.
Gil has been featured in Inc., Forbes, CNBC, Fortune, and Entrepreneurmagazines. He has been named one of Forbes' “30 Under 30” in healthcare, Crain's New York Business 40 Under 40, and Business Insider’s 30 Under 40 in healthcare. In 2020, he was named to Crain’s New York list of the Most Notable in Healthcare, and in 2017, he received their Heritage Healthcare Innovator of the Year award. Gil is currently an Operating Partner at Waterline Ventures and board director for Intus Care. He holds a faculty appointment as an Entrepreneur in-Residence at Harvard Business School. He received a BS in Economics and Biomedical Engineering from Yale and an MBA from Harvard. He sits on the boards of two nonprofits, The New York Academy of Medicine and the Help USA.